Improving cardiovascular disease screening in community mental health centers

Perspectives in Psychiatric Care

Volumn 49, Issue 3, 2013, Pages 179-186

  Maki, Melissa ^a   Bjorklund, Pamela ^b  

^a Human Development Center   (United States)

^b School of Health Science   (United States)

Author keywords

Cardiometabolic risk; Cardiovascular disease (CVD) screening; Process improvement

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY MENTAL HEALTH CENTER; COMORBIDITY; EDUCATION; EQUIPMENT; FEMALE; HUMAN; MALE; MASS SCREENING; MENTAL DISEASE; METHODOLOGY; MIDDLE AGED; MORTALITY; NURSE PRACTITIONER; ORGANIZATION AND MANAGEMENT; PROGRAM EVALUATION; RISK FACTOR; STANDARD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; COMMUNITY MENTAL HEALTH CENTERS; COMORBIDITY; FEMALE; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; NURSE PRACTITIONERS; PROGRAM EVALUATION; RISK FACTORS; YOUNG ADULT;

EID: 84879884859     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2012.00348.x     Document Type: Article

References (18)

1. Baker, D. L. (2002). Successful performance improvement. Association of Operating Room Nurses Journal, 75(4), 825-827.
2. Barnes, T. R., Paton, C., Cavanagh, M. R., Hancock, E., Taylor, D. M.; UK Prescribing Observatory for Mental Health. (2007). A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin, 33, 1397-1403.
3. Buckley, P. F., Miller, D. D., Singer, B., Arena, J., & Stirewalt, E. M. (2005). Clinicians' recognition of the metabolic adverse effects of antipsychotic medications. Schizophrenia Research, 79, 281-288.
4. Chen, Y.-H., Lin, H.-C., & Lin, H.-C. (2010). Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophrenia Bulletin, 37(5), 1-7. Retrieved from http://www.schizophrenia.bulletin.oxfordjournals.org
5. Citrome, L., & Yeomans, D. (2005). Do guidelines for severe mental illness promote physical health and wellbeing? Journal of Psychopharmacology, 19(Suppl. 6), 102-109.
6. Colton, C., & Mandersheid, R. W. (2006). Congruencies in increased mortality rates, years of potential life lost and causes of death among public mental health clients in eight states. Preventing Chronic Disease (serial online), 3(2), 1-14. Retrieved from http://www.cdc.gov/pcd/issues/2006/apr/05_0180.htm
7. Correll, C. U., Druss, B. G., Lombardo, I., O'Gorman, C., Harnett, J. P., Sanders, K. N., ... Cuffel, B. J. (2010). Findings of a U.S. national cardiometabolic screening program among 10, 084 psychiatric outpatients. Psychiatric Services, 61(9), 892-898.
8. Correll, C. U., Harris, J. L., Pantaleon Moya, R. A., Frederickson, A. M., Kane, J. M., & Manu, P. (2007). Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: Missed targets and lost opportunities. Schizophrenia Research, 92, 103-107.
9. Dianis, N. L., & Cummings, C. (1998). An interdisciplinary approach to process performance improvement. Journal of Nursing Care Quality, 12(4), 49-59.
10. Goff, D. C., Sullivan, L. M., & McEvoy, J. P. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80, 43-45.
11. Grundy, S., Cleeman, J., Daniels, S., Donato, K., Eckel, R., Franklin, B., ... Costa, F. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute statement. Circulation, 112, 2735-2752.
12. Joint Commission on Accreditation of Healthcare Organizations. (1994). Framework for improving performance: From principles to practice. Oak Terrace, IL: Author.
13. Merritt, B. O., Morrison, L., Satterwhite, M. W., Smith, A., Thomason, G., & Thompson, J. (Eds.) (2003). The FOCUS-PDCA strategy. Retrieved from http://www.centralstatehospital.org/policy/CCCH/VI%20Performance%20Improvement/6%2003a%20CSH%20Plan%208%2010A%20Focus%20PDCA.pdf
14. Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Stroup, S. T., & Lieberman, J. A. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86, 15-22.
15. Newcomer, J. W., Nasrallah, H. A., & Loebel, A. D. (2004). The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: Practice patterns and knowledge of psychiatrists. Journal of Clinical Psychopharmacology, 24(Suppl. 1), S1-S6.
16. Parks, J., Svendsen, D., Singer, P., & Foti, M. E. (Eds.) (2006). Morbidity and mortality in people with serious mental illness. Alexandria, VA: National Association of State Mental Health Program Directors (NASMHPD) Medical Directors' Council. Retrieved from http://www.nasmphpd.org
17. Ramsey, C., Ormsby, S., & Marsh, T. (2000). Performance-improvement strategies can reduce costs. Healthcare Financial Management, 54(12), 2-6.
18. Redick, E. L. (1999). Applying FOCUS-PDCA to solve clinical problems. Dimensions in Critical Care Nursing, 18(6), 30-34.